Netherlands
Dutch government should not subsidise weight-loss drug Wegovy, adviser says
AMSTERDAM (Reuters) - Novo Nordisk's hugely popular weight-loss drug Wegovy should not be covered under the basic insurance of the Netherlands, the country's healthcare institute said in an advice to the Dutch government.
reuters_tickers
1 minute
AMSTERDAM (Reuters) – Novo Nordisk’s hugely popular weight-loss drug Wegovy should not be covered under the basic insurance of the Netherlands, the c... [847 chars]
Related
Share this page
Guest Posts by Easy Branches
